Correlation Between Akums Drugs and Piramal Enterprises

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akums Drugs and Piramal Enterprises at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akums Drugs and Piramal Enterprises into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akums Drugs and and Piramal Enterprises Limited, you can compare the effects of market volatilities on Akums Drugs and Piramal Enterprises and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akums Drugs with a short position of Piramal Enterprises. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akums Drugs and Piramal Enterprises.

Diversification Opportunities for Akums Drugs and Piramal Enterprises

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Akums and Piramal is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Akums Drugs and and Piramal Enterprises Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Piramal Enterprises and Akums Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akums Drugs and are associated (or correlated) with Piramal Enterprises. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Piramal Enterprises has no effect on the direction of Akums Drugs i.e., Akums Drugs and Piramal Enterprises go up and down completely randomly.

Pair Corralation between Akums Drugs and Piramal Enterprises

Assuming the 90 days trading horizon Akums Drugs and is expected to under-perform the Piramal Enterprises. In addition to that, Akums Drugs is 1.53 times more volatile than Piramal Enterprises Limited. It trades about -0.19 of its total potential returns per unit of risk. Piramal Enterprises Limited is currently generating about 0.1 per unit of volatility. If you would invest  112,265  in Piramal Enterprises Limited on September 15, 2024 and sell it today you would earn a total of  12,965  from holding Piramal Enterprises Limited or generate 11.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.41%
ValuesDaily Returns

Akums Drugs and  vs.  Piramal Enterprises Limited

 Performance 
       Timeline  
Akums Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Piramal Enterprises 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Piramal Enterprises Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent technical and fundamental indicators, Piramal Enterprises may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Akums Drugs and Piramal Enterprises Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akums Drugs and Piramal Enterprises

The main advantage of trading using opposite Akums Drugs and Piramal Enterprises positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akums Drugs position performs unexpectedly, Piramal Enterprises can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Piramal Enterprises will offset losses from the drop in Piramal Enterprises' long position.
The idea behind Akums Drugs and and Piramal Enterprises Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges